Sale!

FLT3 Gene Mutation Quantitative Monitor Test

750 د.إ

-10%

The FLT3 Gene Mutation Quantitative Monitor Test is a specialized diagnostic procedure designed to detect and quantify mutations in the FLT3 gene, which is a critical factor in the development and progression of certain types of leukemia, particularly Acute Myeloid Leukemia (AML). This test plays a vital role in the diagnosis, prognosis, and management of patients with leukemia, as FLT3 mutations are associated with a higher risk of disease relapse and a poorer overall prognosis. By accurately quantifying the mutation levels, healthcare providers can tailor treatment plans more effectively, monitor response to therapy, and adjust strategies as needed to improve patient outcomes.

Performed at DNA Labs UAE, a state-of-the-art facility known for its advanced genetic testing capabilities, the FLT3 Gene Mutation Quantitative Monitor Test is available for a cost of 750 AED. DNA Labs UAE employs cutting-edge technology and adheres to stringent quality standards to ensure accurate and reliable test results, providing essential information for the optimal management of patients with leukemia.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

FLT3 GENE MUTATION QUANTITATIVE MONITOR Test

Test Name: FLT3 GENE MUTATION QUANTITATIVE MONITOR Test

Components: Price 750.0 AED

Sample Condition: 5 mL (3 mL min.) whole blood / Bone marrow in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled MRD Requisition Form (Form 22) with historical data is mandatory.

Report Delivery: Sample Mon / Thu by 11 am; Report Wed / Sat

Method: Real Time PCR

Test type: Leukemias

Doctor: Hematologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: Duly filled MRD Requisition Form (Form 22) with historical data is mandatory.

Test Details

The FLT3 gene mutation quantitative monitor test is a diagnostic tool used to measure the quantity of FLT3 gene mutations in a patient’s blood or bone marrow sample. FLT3 gene mutations are commonly found in patients with acute myeloid leukemia (AML) and are associated with a poorer prognosis.

The test uses polymerase chain reaction (PCR) technology to amplify and detect specific DNA sequences associated with FLT3 gene mutations. It can identify both internal tandem duplications (ITDs) and point mutations in the FLT3 gene.

The FLT3 gene mutation quantitative monitor test is important for monitoring the progression of AML and determining the effectiveness of treatment. It can provide information on the quantity of FLT3 gene mutations present in a patient’s sample, which can help guide treatment decisions.

The results of the test are reported as a percentage of mutated FLT3 alleles out of the total FLT3 alleles present. A higher percentage indicates a higher burden of FLT3 gene mutations, which may indicate a more aggressive form of AML.

Overall, the FLT3 gene mutation quantitative monitor test is a valuable tool in the management of AML patients, allowing for the monitoring of disease progression and treatment response.

Test Name FLT3 GENE MUTATION QUANTITATIVE MONITOR Test
Components
Price 750.0 AED
Sample Condition 5 mL (3 mL min.) whole blood \/ Bone marrow in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filledMRD Requisition Form (Form 22) with historical data is mandatory.
Report Delivery SampleMon / Thu by 11 am; Report Wed / Sat
Method Real Time PCR
Test type Leukemias
Doctor Hematologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filledMRD Requisition Form (Form 22) with historical data is mandatory.
Test Details

The FLT3 gene mutation quantitative monitor test is a diagnostic tool used to measure the quantity of FLT3 gene mutations in a patient’s blood or bone marrow sample. FLT3 gene mutations are commonly found in patients with acute myeloid leukemia (AML) and are associated with a poorer prognosis.

The test uses polymerase chain reaction (PCR) technology to amplify and detect specific DNA sequences associated with FLT3 gene mutations. It can identify both internal tandem duplications (ITDs) and point mutations in the FLT3 gene.

The FLT3 gene mutation quantitative monitor test is important for monitoring the progression of AML and determining the effectiveness of treatment. It can provide information on the quantity of FLT3 gene mutations present in a patient’s sample, which can help guide treatment decisions.

The results of the test are reported as a percentage of mutated FLT3 alleles out of the total FLT3 alleles present. A higher percentage indicates a higher burden of FLT3 gene mutations, which may indicate a more aggressive form of AML.

Overall, the FLT3 gene mutation quantitative monitor test is a valuable tool in the management of AML patients, allowing for the monitoring of disease progression and treatment response.